Skip to main content
TVTX logo

TVTX · Travere Therapeutics, Inc. · Proposed Sales

Track TVTX — free
$48.80 -1.45 (-2.88%) Play latest call Q3 2026 earnings call transcript
Market Cap
$4.82B
Shares
95.99M
Volume · Nov 19 420.93K Avg daily vol (3M) 1.82M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-10-15 ERIC DUBE 243,735
2026-09-17 ERIC DUBE 108,493
2026-09-17 PETER HEERMA 8,282
2026-09-16 ERIC DUBE 195,841
2026-09-16 WILLIAM ROTE 112,850
2026-09-16 PETER HEERMA 172,717
2026-09-15 WILLIAM ROTE 96,198
2026-09-15 JULA INRIG 44,674
2026-09-15 ELIZABETH REED 39,576
2026-09-15 SANDRA CALVIN 5,375
2026-09-15 CHRISTOPHER CLINE 50,508
2026-09-15 PETER HEERMA 102,190
2026-09-15 ERIC DUBE 95,666
2026-09-10 JEFFREY MECKLER 20,000
2026-08-18 GARY LYONS 5,000
2026-08-17 GARY A LYONS 5,000
2026-06-12 ROY BAYNES 4,500
2026-06-12 Coughlin Timothy 10,000
2026-05-15 Coughlin Timothy 3,250
2026-05-06 ELIZABETH REED 2,076
2026-05-06 JULA INRIG 311
2026-05-06 Dube Eric M 22,500
2026-05-06 ROTE WILLIAM E. 2,763
2026-05-06 CHRISTOPHER CLINE 310
2026-05-05 Jula Inrig 2,174
2026-05-05 Christopher Cline 2,181
2026-05-05 ROY BAYNES 4,500
2026-05-05 Peter Heerma 2,174
2026-05-05 Elizabeth E. Reed 2,174
2026-05-04 JEFFREY MECKLER 8,000
2026-05-04 JULA INRIG 20,000
2026-05-04 ELIZABETH REED 20,000
2026-05-01 ROY BAYNES 9,750
2026-04-22 ROTE WILLIAM E. 9,100
2026-04-15 CHRISTOPHER CLINE 1,014
2026-04-15 ELIZABETH REED 6,785
2026-04-15 Dube Eric M 64,000
2026-04-15 JULA INRIG 1,018
2026-04-14 Peter Heerma 7,215
2026-04-14 Jula Inrig 7,215
2026-04-14 Elizabeth E. Reed 7,215
2026-04-14 GARY A LYONS 8,000
2026-04-14 CHRISTOPHER CLINE 9
2026-04-14 ELIZABETH REED 37,500
2026-04-14 SANDRA CALVIN 21,977
2026-04-14 ROY BAYNES 32,750
2026-04-14 Christopher Cline 7,239
2026-04-13 Christopher Cline 65
2026-04-06 ROY BAYNES 10,000
2026-04-01 Dube Eric M 60,000
Showing 1–50 of 131 filings
Key facts CIK 1438533 CUSIP 89422G107 13F (30d) 353 filings 328 filers Visit website Investor relations